Your browser doesn't support javascript.
loading
Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.
Kumada, Hiromitsu; Watanabe, Tsunamasa; Suzuki, Fumitaka; Ikeda, Kenji; Sato, Ken; Toyoda, Hidenori; Atsukawa, Masanori; Ido, Akio; Takaki, Akinobu; Enomoto, Nobuyuki; Kato, Koji; Alves, Katia; Burroughs, Margaret; Redman, Rebecca; Pugatch, David; Pilot-Matias, Tami J; Krishnan, Preethi; Oberoi, Rajneet K; Xie, Wangang; Chayama, Kazuaki.
Afiliação
  • Kumada H; Department of Hepatology, Toranomon Hospital, Tokyo, Japan. kumahiro@toranomon.gr.jp.
  • Watanabe T; Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Suzuki F; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Ikeda K; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Sato K; Department of Medicine and Molecular Science, Gunma University Hospital, Maebashi, Japan.
  • Toyoda H; Department of Gastroenterology, Ogaki Municipal Hospital, Gifu, Japan.
  • Atsukawa M; Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Ido A; Department of Human and Environmental Sciences, Kagoshima University Hospital, Kagoshima, Japan.
  • Takaki A; Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Enomoto N; The First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Kato K; AbbVie Inc., North Chicago, IL, USA.
  • Alves K; AbbVie Inc., North Chicago, IL, USA.
  • Burroughs M; AbbVie Inc., North Chicago, IL, USA.
  • Redman R; AbbVie Inc., North Chicago, IL, USA.
  • Pugatch D; AbbVie Inc., North Chicago, IL, USA.
  • Pilot-Matias TJ; AbbVie Inc., North Chicago, IL, USA.
  • Krishnan P; AbbVie Inc., North Chicago, IL, USA.
  • Oberoi RK; AbbVie Inc., North Chicago, IL, USA.
  • Xie W; AbbVie Inc., North Chicago, IL, USA.
  • Chayama K; Department of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Hiroshima University Hospital, Hiroshima, Japan.
J Gastroenterol ; 53(4): 566-575, 2018 Apr.
Article em En | MEDLINE | ID: mdl-29052790
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Quinoxalinas / Sulfonamidas / Benzimidazóis / Hepacivirus / Hepatite C Crônica / Insuficiência Renal Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Gastroenterol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Quinoxalinas / Sulfonamidas / Benzimidazóis / Hepacivirus / Hepatite C Crônica / Insuficiência Renal Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Gastroenterol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão